Company Filing History:
Years Active: 2017
Title: Anderson Mark: Innovator in Therapeutic Molecules
Introduction
Anderson Mark is a notable inventor based in Spring House, PA (US). He has made significant contributions to the field of therapeutic molecules, particularly in the development of binding molecules that target specific domains.
Latest Patents
Mark holds a patent for "EGFR and c-Met fibronectin type III domain binding molecules." This patent includes monospecific and bispecific EGFR and/or c-Met FN3 domain containing molecules, isolated nucleotides encoding the molecules, vectors, host cells, and methods of making them. These innovations are useful in the generation of therapeutic molecules and the treatment and diagnosis of various diseases and disorders.
Career Highlights
Anderson Mark is currently employed at Janssen Biotech, Inc., where he continues to advance his research and development efforts. His work has the potential to impact the medical field significantly, particularly in the area of targeted therapies.
Collaborations
Mark collaborates with esteemed colleagues, including Ricardo Attar and Michael Diem, to further enhance the scope and application of his inventions.
Conclusion
Anderson Mark's contributions to the field of therapeutic molecules exemplify the innovative spirit of modern science. His work not only advances medical research but also holds promise for improving patient outcomes in the treatment of diseases.